Exploration of Artemisinin Against IgA Nephropathy via AKT/Nrf2 Pathway by Bioinformatics and Experimental Validation.

Drug Des Devel Ther · 2023 · PMC10257916 · PMID 37309415

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a decreasing trendno p-value reported

Meanwhile, the cellular LN mRNA level was significantly increased in the LPS group compared with the control group, and there was a decreasing trend of FN, LN and Col4 mRNA in the artemisinin group, among which the LN mRNA expression was significantly different ( Figure 10D ).

also in 47,180 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.